Plantar Fascia Rupture in Elite Athlete of Volleyball - Case Report
International Physical Medicine & Rehabilitation Journal · 2017
DOI: 10.15406/ipmrj.2017.01.00016 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Physical Medicine & Rehabilitation Journal, 2017. Verfasst von Alexandre de Paiva Luciano. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
The literature explains its pathophysiology through a process where mechanical overload and excessive stress produce intrasubstantial microruptures in the plantar fascia.In high-performance athletes (elite), involved in running and jumping, repeated daily heel trauma without the recommended interval may hinder normal healing, can resulting in a rupture the plantar fascia.The plantar fascia rupture resulting from chronic local inflammation or previous infiltration with corticosteroids may occur spontaneously during elite athletic activity.The objective of this case report is to document the diagnosis, treatment proposal and time of return to the sport activity of Olympic athletes and volleyball professionals, whilst in the National League matches, after a start, reported audible click and sudden pain in right foot plantar region with impossibility of movement and march.It evolved with acute plantar fascia rupture without history of previous infiltrations of corticosteroids, entity rarely described in literature.
Zitieren
APA
Luciano, A. D. P. (2017). Plantar Fascia Rupture in Elite Athlete of Volleyball - Case Report. International Physical Medicine & Rehabilitation Journal. https://doi.org/10.15406/ipmrj.2017.01.00016
Vancouver
Luciano ADP. Plantar Fascia Rupture in Elite Athlete of Volleyball - Case Report. International Physical Medicine & Rehabilitation Journal. 2017. doi:10.15406/ipmrj.2017.01.00016
BibTeX
@article{Luciano2017,
author = {Luciano, Alexandre de Paiva},
title = {Plantar Fascia Rupture in Elite Athlete of Volleyball - Case Report},
journal = {International Physical Medicine & Rehabilitation Journal},
year = {2017},
doi = {10.15406/ipmrj.2017.01.00016}
}
EUVIMED